mianserin has been researched along with Cannabis Abuse in 3 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cannabinoid hyperemesis is a cluster of symptoms characterized by chronic cannabis abuse, cyclical vomiting and compulsive bathing behaviours." | 1.34 | Cannabinoid hyperemesis: marijuana puts patients in hot water. ( Martin, AL; Park, B; Wallace, D, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haney, M | 1 |
| Hart, CL | 1 |
| Vosburg, SK | 1 |
| Comer, SD | 1 |
| Reed, SC | 1 |
| Cooper, ZD | 1 |
| Foltin, RW | 1 |
| Wallace, D | 1 |
| Martin, AL | 1 |
| Park, B | 1 |
| Benyamina, A | 1 |
| Lecacheux, M | 1 |
| Blecha, L | 1 |
| Reynaud, M | 1 |
| Lukasiewcz, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Baclofen on Marijuana Withdrawal and Relapse[NCT00373295] | Phase 2 | 13 participants (Actual) | Interventional | 2006-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"This is a measure of marijuana self-administration and relapse since each initial puff costs $7 and is a burden to overcome just to smoke.~Over each 3 day period, the puffs chosen by each participant is averaged for a single value." (NCT00373295)
Timeframe: Days 1-3 (Baseline) and Days 6-8 (Relapse Phase)
| Intervention | dollars spent on marijuana (Mean) |
|---|---|
| Baclofen 60, Marijuana | 7.15 |
| Placebo, Marijuana | 9.77 |
| Baclofen 90, Marijuana | 7.25 |
1 review available for mianserin and Cannabis Abuse
| Article | Year |
|---|---|
Pharmacotherapy and psychotherapy in cannabis withdrawal and dependence.
Topics: Behavior Therapy; Buspirone; Cannabinoids; Cognitive Behavioral Therapy; Combined Modality Therapy; | 2008 |
1 trial available for mianserin and Cannabis Abuse
| Article | Year |
|---|---|
Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse.
Topics: Adrenergic alpha-Antagonists; Adult; Affect; Baclofen; Cognition; Dose-Response Relationship, Drug; | 2010 |
1 other study available for mianserin and Cannabis Abuse
| Article | Year |
|---|---|
Cannabinoid hyperemesis: marijuana puts patients in hot water.
Topics: Abdominal Pain; Adult; Antidepressive Agents, Tricyclic; Cannabinoids; Cognitive Behavioral Therapy; | 2007 |